RedHawk Pharma LLC is in negotiations to purchase undisclosed cannabis assets in Oklahoma.
The news was announced Friday by parent company RedHawk Holdings Corp. SNDD, a diversified holding company focused on sales and distribution of medical devices.
According to the press release, specific cannabis assets include licenses to grow, manufacture, and sell within the state.
The company stressed that the focus is on "craft" cultivation as well as the distribution of product.
The potential deal closing would take place before the year-end.
It is subject to the approval of RedHawk's board of directors as well as acceptance and approval by the seller's board of directors and shareholders, among others.
The Lafayette, Louisiana-based company is also engaged in sales of branded generic pharmaceutical drugs, while it has its fair share in commercial real estate investment as well.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!